Inventor · disambiguated record
Kuo-Hsiang Chuang
Also filed as: CHUANG KUO-HSIANG
11 granted patents·8 pending applications·5 citations·filing 2010–2023
80Inventor score
Top patents by PatentIndex Score
19 records- 0175US8507207B2Recombinant nucleotide sequence, cell or vector containing the same and method for using cell containing the same to encode anti-polyethylene glycol monoclonal antibodiesCHENG TIAN-LU·Filed 2010·Granted Aug 13, 2013·2 cites·5 claims
- 0271US10188742B2Bi-specific antibodies and uses thereofACADEMIA SINICA·Filed 2015·Granted Jan 29, 2019·2 cites·6 claims
- 0367US2021292438A1Conditional internalization of pegylated agents by pretargeting bi-specific peg-binding antibodies for diagnosis and therapyACADEMIA SINICA·Filed 2021·Application pending·0 cites
- 0464US9315815B2Method of high-throughput sorting of high expression cell and cells sorted therefromUNIV TAIPEI MEDICAL·Filed 2014·Granted Apr 19, 2016·1 cites·14 claims
- 0559US2024398823A1Dual inhibitor of histone deacetylase 6 and heat shock protein 90UNIV TAIPEI MEDICAL·Filed 2022·Application pending·0 cites
- 0657US2022202954A1High-density and short-chain peg modified nano-sized carriers and their usesUNIV TAIPEI MEDICAL·Filed 2021·Application pending·0 cites
- 0755US2024139251A1Antigen-specific t cells, methods of producing the same, and uses thereofCYTOARM CO LTD·Filed 2023·Application pending·0 cites
- 0852US10634666B2Non-obese diabetes mice and its applicationsUNIV TAIPEI MEDICAL·Filed 2016·Granted Apr 28, 2020·0 cites·8 claims
- 0950US2025127894A1Process for producing armed immune cellsCYTOARM CO LTD·Filed 2022·Application pending·0 cites
- 1048US11571476B2Anti-tumor/anti-tumor associated fibroblast/anti-hapten trispecific antibodies and use thereofUNIV TAIPEI MEDICAL·Filed 2017·Granted Feb 7, 2023·0 cites·12 claims
- 1148US11320427B2Tandemly repeated antibody-binding protein and its applicationsUNIV TAIPEI MEDICAL·Filed 2017·Granted May 3, 2022·0 cites·11 claims
- 1248US11040111B2Bi-specific antibodies and uses thereofACADEMIA SINICA·Filed 2018·Granted Jun 22, 2021·0 cites·11 claims
- 1348US2020140572A1Conditional internalization of pegylated agents by pretargeting bi-specific peg-binding antibodies for diagnosis and therapyROFFLER STEVE·Filed 2018·Application pending·0 cites
- 1447US11369690B2Bi-specific antibodies and uses thereofACADEMIA SINICA·Filed 2018·Granted Jun 28, 2022·0 cites·11 claims
- 1544US11680107B2Hydrogel composition for drug delivery and uses thereofUNIV TAIPEI MEDICAL·Filed 2020·Granted Jun 20, 2023·0 cites·24 claims
- 1643US2024209084A1Bi-specific antibodies for use in producing armed immune cellsCYTOARM CO LTD·Filed 2021·Application pending·0 cites
- 1742US9329180B2Preparation of anti-PEG antibody expressing cell and application thereofUNIV KAOHSIUNG MEDICAL·Filed 2013·Granted May 3, 2016·0 cites·15 claims
- 1841US11913025B2Antigen-specific T cells and uses thereofCYTOARM CO LTD·Filed 2018·Granted Feb 27, 2024·0 cites·2 claims
- 1929US2012015380A1Anti-polyethylene glycol antibody expressing cell quantify any free polyethylene glycol and polyethylene glycol-derivatized moleculesCHENG TIAN-LU·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kuo-Hsiang Chuang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →